PATRICK HASSENFRITZ: Open Payments
NPI 1992348999 · CAMAS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 7 payments from 5 companies in 2025. Trend: 2023 $49 · 2024 $72 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $212 |
| ABBVIE INC. | 2 | $149 |
| Otsuka America Pharmaceutical, Inc. | 1 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: SPRAVATO, VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX.
Industry payments across WA — which companies pay providers there.
